Physician profile
Hal Hockfield
NPI 1477559920
$11,313.86
in general payments reported to CMS, 2019-2025
45 companies · $2,751 in 2025
The $2,751 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,363 · 2020: $814 · 2021: $630 · 2022: $448 · 2023: $661 · 2024: $2,647 · 2025: $2,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,058.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,242.82 | 2019-2025 | |
| Novo Nordisk INC | $1,079.13 | 2019-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $1,076.72 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $897.58 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $824.62 | 2019-2025 | Mounjaro, Kisunla |
| Amgen INC. | $683.89 | 2019-2025 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $571.90 | 2019-2022 | |
| Astellas Pharma US INC | $346.11 | 2019-2025 | Veozah |
| Merck Sharp & Dohme LLC | $303.10 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Abbott Laboratories | $298.91 | 2024-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $289.44 | 2024-2025 | |
| Abbvie INC. | $267.30 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.96 | 2019-2025 | Jardiance |
| Eisai INC. | $214.82 | 2024 | |
| Amarin Pharma, INC. | $184.97 | 2019 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hal Hockfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.